Proteolysis-targeting chimeras (#PROTACs) are a new class of drugs capable of exploiting a cell’s machinery. Find out how you can use the @OpenTargets Platform to identify suitable PROTACs for your #drugdiscovery research. https://t.co/AARDXrnXzl
— EMBL-EBI (@emblebi) July 21, 2021
Post a Comment
Thanks for reading my blog.
Note: only a member of this blog may post a comment.